Market Opportunity

$16 BILLION/YEAR

Worldwide, three million Pulmonary Fibrosis Patients

In the US, there are 160,000 Pulmonary Fibrosis patients

Annual cost of a branded agent ~$100,000 year

There are approximately 160,000 Pulmonary Fibrosis patients in the U.S. Current cost per year of a brand product is ~$100,000 per year. Therefore, the total U.S. market opportunity for LGM2605 is ~$16 Billion per year